SCCA2 as a biomarker reflecting patient‐reported disease burden in children with mild atopic dermatitis under maintenance therapy
SCCA2 reflects patient-experienced symptom burden more closely than physician-assessed severity in mild AD. Its short-term, time-dependent association with POEM suggests potential utility for identifying early or imminent symptom burden.
Authors
- Takafumi Takase
- Mayumi Matsunaga (ORCID: https://orcid.org/0000-0001-5152-6617)
- T Fujisawa
- Kazutaka Nogami
- Yoshinori Azuma (ORCID: https://orcid.org/0000-0002-5842-8654)
- Kana Hamada (ORCID: https://orcid.org/0000-0003-2182-9822)
- Fumiko Iwai
- M Nagao
- Yasuaki Yasuda
- Shigeru Suga (ORCID: https://orcid.org/0000-0002-8002-6504)
- Masahiro Hirayama (ORCID: https://orcid.org/0000-0002-6850-2782)
- Miyuki Hoshi‐Funakawa
- Kenji Izuhara
Institutions
- Mie University (JP)
- Saga Medical School Hospital (JP)
- National Sagamihara Hospital (JP)
- National Mie Hospital (JP)
Publication Details
- Journal
- Pediatric Allergy and Immunology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/pai.70298
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00